Helius Medical Technologies (HSDT) Expected to Announce Earnings on Monday

Helius Medical Technologies (NASDAQ:HSDT) will likely be announcing its Q1 2025 earnings results before the market opens on Monday, May 12th. Analysts expect Helius Medical Technologies to post earnings of ($0.92) per share and revenue of $0.10 million for the quarter.

Helius Medical Technologies (NASDAQ:HSDT) last issued its earnings results on Thursday, May 1st. The company reported ($0.51) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.58) by $0.07. Helius Medical Technologies had a negative net margin of 1,764.74% and a negative return on equity of 244.82%. The company had revenue of $0.05 million during the quarter.

Helius Medical Technologies Trading Down 2.3 %

NASDAQ HSDT opened at $4.20 on Friday. The company has a market capitalization of $1.72 million, a PE ratio of -0.68 and a beta of 1.11. The firm’s fifty day simple moving average is $5.26 and its 200-day simple moving average is $7.75. Helius Medical Technologies has a 1-year low of $3.32 and a 1-year high of $26.35.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.